The Strategic Contributions of Indian Operations in AMRI’s Global Outsourcing Organization
White Paper Jan 23, 2013
The concept of outsourcing, though late in adoption by pharma¬ceutical research and development organizations relative to other industries, has gained strong acceptance over the past 15 years, and Contract Research Organizations (CROs) have been established to meet most of the needs of the research industry. Furthermore, with¬in the past decade, factors pointed to by Thomas Friedman in his ‘flattening’ of the earth thesis, coupled with the return to India and China of highly educated and trained industrial scientists, and the institution of stronger controls on the treatment of intellectual prop¬erty in these countries have led to the creation and rapid growth of a competitive sector of low cost, contract services organizations that have experienced rapid acceptance and today successfully compete with Western-based CROs.
Related White Papers
7 Key Factors When Considering a Benchtop X-ray DiffractometerWhite Paper
In this white paper, our marketing director of the America’s Kathy Macchiarola outlines the important decisions factors that are key requirements and help you select a benchtop system ideal for your situation and your needs.READ MORE
Supporting the Pharmaceutical Industry with 21 CFR Part 11 Compliance ReadinessWhite Paper
The purpose of this document is to describe how PANalytical systems support system owners meeting the requirements of the 21 CFR Part 11 regulations issued by the United States’ FDA.READ MORE